Metformin improves endothelial dysfunction via the liver kinase B1 (LKB1)/adenosine monophosphate-activated protein kinase (AMPK) pathway [48] and may potentially have affected the baseline and endothelial protein response to hypoglycemia. This evidence concerns the gene STK11 and endothelial dysfunction.